Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Compr Psychiatry. 2012 Mar 16;53(7):1028–1033. doi: 10.1016/j.comppsych.2012.02.003

Table 2.

Anthropometric and lab measurements1

Patients with
Schizophrenia or
Schizoaffective
Disorder		 NHANES Significance
HbA1C (%) 6.4 ± 1.3 (n=112) 6.0 ± 1.3 (n=238) p≤ .01**
Waist circumference
(cm) 		119.2 ± 15.2 (n=119) 115.1 ± 14.8 (n=244) p≤ .05*
Systolic pressure
(mmHg) 		126.0 ± 17.2 (n=121) 124.0 ± 14.9 (n=246) NS
Diastolic pressure
(mmHg) 		80.0 ± 11.8 (n=121) 74.7 ± 10.8 (n=245) p ≤ .01**
Glucose (mg/dl) 111.0 ± 38.7 (n=110) 114.8 ± 50.7 (n=118) NS
Insulin (uU/L) 22.0 ± 19.2 (n=109) 16.9 ± 12.4 (n=117) p≤ .05*
Triglycerides (mg/dl) 133.6 ± 60.6 (n=110) 159.0 ± 135.2 (n=116) NS
LDL cholesterol
(mg/dl) 		106.8 ± 37.0 (n=110) 121.2 ± 38.5 (n=111) p≤ .01**
HDL cholesterol
(mg/dl) 		47.9 ± 16.7 (n=110) 49.9 ± 14.4 (n=237) NS
Total cholesterol
(mg/dl) 		181.2 ± 42.7 (n=110) 200.4 ± 45.0 (n=237) p≤ .01**
1

All values are means ± SDs. P values derived from independent t tests.

*

p ≤ 0.05

**

p ≤ 0.01